EXACT SCIENCES CORP is 4.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($20.03 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAI | EXAS |
|---|---|---|
| Market cap | $4.85 B | $20.03 B |
| US-listed rank | #1404 | #619 |
| Revenue (latest FY) | $812.03M | $3.25B |
| Net income (latest FY) | -$68.09M | -$207.95M |
| Net margin | -8.4% | -6.4% |
| SEC filings | 102 | 1,834 |
EXACT SCIENCES CORP is 4.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($20.03 B vs $4.85 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while EXACT SCIENCES CORP reported $3.25B.
Full pages: Caris Life Sciences, Inc. and EXACT SCIENCES CORP, or browse the full rankings.